Hidden Epidemic of Monkey Virus

[Guest guest]

 

 

 

 

 

 

 

 

 

 

Fri Oct 15 13:56:11 2004 Pacific Time

Hidden Epidemic of Monkey Virus Infections Arose From

Contaminated Polio Vaccines, Researcher Says

ROSEMEAD, Calif., Oct. 15 (AScribe Newswire) -- The Centers

for Disease Control and Prevention (CDC) was recently notified of an

individual infected with a monkey cytomegalovirus. Previous reports to

CDC of infections with viruses that originated from African green

monkeys have largely gone ignored, according to Dr. W. John Martin,

M.D., Ph.D., founder of the privately funded Centers for Complex

Infectious Diseases in Rosemead, California. "Public health officials

have been very resistant, since any airing of this topic will lead to

the inevitable conclusion that the government erred in accepting

cytomegalovirus contamination of the African green monkeys used in

polio vaccine production."

In a 1972 joint

government-industry study cited by Dr. Martin, cell cultures from all

11 monkeys studied were contaminated with simian cytomegalovirus. The

scientific community was not informed of this finding. In spite of

industry's efforts to curtail contamination, Food and Drug

Administration (FDA) officials have confirmed that 3 of 8 licensed

polio vaccines released in 1976 have DNA of simian cytomegalovirus.

Martin referred to these results in an October 2002 meeting of the

Institute of Medicine. His manuscript entitled "DNA Analysis of a

Stealth-Adapted Simian Cytomegalovirus" was removed from the published

proceedings of the conference.

Martin contends that many

of the diseases of epidemic proportions in this county, including

autism and attention deficit hyperactivity disorder in children, as

well as cancer, chronic fatigue, fibromyalgia and Alzheimer's-like

illnesses in adults, are caused by stealth-adapted viruses.

Stealth-adaptation is a process whereby cell-damaging viruses lose

components that are normally targeted by the immune system. Some, but

not all stealth-adapted viruses are derived from simian

cytomegalovirus. Increasingly, Martin is hearing of family illnesses of

presumptive infectious origin. He recently submitted a manuscript

entitled "Complex multi-system illnesses occurring within a family:

Presumptive evidence for an infectious disease process" to the CDC

Journal of Emerging Infectious Diseases, but its publication was

declined. "It is hard to wake them up" says Martin "and near impossible

to break through the self protective barrier of those who recognize

that cytomegalovirus contaminated polio vaccines used in Central Africa

could have triggered the formation of the AIDS virus. CDC has a

collection of sera from polio vaccine immunized African children that,

under better leadership, would have been tested for cytomegalovirus

antibodies." Except for legal purposes, Martin has been prohibited from

communicating results of stealth virus testing to individuals with

complex unexplained illnesses. A petition recently sent to CDC

requesting that it tests autistic children for stealth-adapted viruses

was seemingly futile.

"The real tragedy of CDC," says

Martin "is the public's expectation that it will aggressively pursue

every indication of potentially infectious agents contributing to human

diseases. Doing nothing is tantamount to allowing disease to go

unchecked. One way to establish dialogue with the CDC is through the

litigation process. Alternatively, a Congressman or Senator willing to

risk the ire of the pharmaceutical industry must insist that CDC

immediately address the issue of cytomegalovirus contamination of polio

virus vaccines and interview some of the many patients infected with

stealth-adapted viruses."

Dr. Martin says, "Now is the

time for well designed clinical studies to evaluate methods to prevent

disease transmission and to help restore normal brain function to

stealth-adapted virus infected individuals. The public needs to be

informed and our Government agencies need to respond."

More information, including copies of the manuscripts submitted to the

Institute of Medicine and CDC Journal of Emerging Infectious Diseases,

is available at www.s3support.com

CONTACT: W. John

Martin, M.D., Ph.D., Director, Center for Complex Infectious Diseases,

Rosemead CA 91770, 626-616-2868, s3support

---

BIO/C.V.

W. John Martin

Education

o University of Sydney Australia . Graduated B.Sc. (Med) in

1963 and M.B., B.S. (M.D. equivalent) in 1965.

o Medical Residency at Royal Prince Alfred Hospital, Sydney,

Australia 1965-1966.

o University of Melbourne . Ph.D. in Immunology 1967-1979.

o Post-doctoral training at the National Institutes of Allergy and

Infectious Diseases, NIH (1970); Pathology Department, Harvard Medical

School (1971), National Cancer Institute, NIH (1972) and University

College London (1973-1974).

o Pathology Residency, National Naval Center, Bethesda

Maryland (1980-1985)

Academic Appointments

o Visiting Scientist and Expert National Cancer Institute,

NIH, Bethesda , MD 1/71-9/72; 2/74-1/76

o Supervisory Medical Officer GS-14 and Head, Oncology Unit, Division

of Virology, Bureau of Biologics, Food and Drug Administration, NIH,

Bethesda, MD 1/76-2/81

o Supervisory Medical Officer

GS-15 and Head, Biological Resources Branch, Biological Response

Modifiers Program, National Cancer Institute, NIH, Bethesda , MD

3/81-1/82

o Associate Professor of Pathology, Uniformed Services,

University of the Health Sciences, Bethesda , MD 1/82-6/85

o Professor of Pathology, University of Southern California School of

Medicine 7/85 - present. Tenured position with leave granted from 1996.

 

Clinical Appointments

o Chief of

Immunology/Immunopathology Unit, Section of Laboratories and Pathology,

Los Angeles County + University of Southern California Medical Center,

Los Angeles , CA 7/85-6/93. Unit name change to Immunology/Molecular

Pathology 7/88. Director of Flow Cytometry, 6/93 to 10/95

o Director of USC Infectious Diseases Laboratory and of USC Molecular

Pathology Laboratory within the USC Clinical Laboratories, USC School

of Medicine 1/88-10/95

Other Positions

o

Founder and Director, Center for Complex Infectious Diseases, Rosemead,

California 91770 (A research and clinical laboratory testing facility

supported by donations and other funding managed by the National

Heritage Foundation)

Board Certification

o Diplomat of the American Board of Medical Laboratory

Immunology 1983

o Diplomat of the American Board of Pathology in Anatomic and

in Clinical Pathology 1984

o Special Competence Certification in Immunopathology,

American Board of Pathology, 1984

o Special Competence Certification in Medical Microbiology,

American Board of Pathology 1985

-30-

 

 

 

 

 

 

Sonya PLoS Medicine

The open-access general medical journal from the Public Library of

Science

Inaugural issue: Autumn 2004 Share your discoveries with the world.

http://www.plosmedicine.org